GC/EVP, Leg Affairs of Seagen Inc (30-Year Financial, Insider Trades) Jean I Liu (insider trades) sold 5,000 shares of SGEN on 01/15/2021 at an average price of $180 a share. The total sale was $900,000.
Seattle Genetics Inc is a biotechnology company. The company is focused on development and commercialization of targeted therapies for the treatment of cancer. Its products are ADCETRIS (brentuximab vedotin) US and ADCETRIS (brentuximab vedotin) Canada. Seagen Inc has a market cap of $33.25 billion; its shares were traded at around $185.750000 with a P/E ratio of 73.13 and P/S ratio of 17.70. GuruFocus has detected 1 severe warning sign with Seagen Inc. .
CEO Recent Trades:
- President and CEO Clay B Siegall sold 29,353 shares of SGEN stock on 01/07/2021 at the average price of $172.44. The price of the stock has increased by 7.72% since.
CFO Recent Trades:
- CFO Todd E Simpson sold 33,669 shares of SGEN stock on 12/18/2020 at the average price of $200. The price of the stock has decreased by 7.13% since.
Directors and Officers Recent Trades:
- GC/EVP, Leg Affairs Jean I Liu sold 5,000 shares of SGEN stock on 01/15/2021 at the average price of $180. The price of the stock has increased by 3.19% since.
For the complete insider trading history of SGEN, click here
.
